EUCTR2020-002204-38-DK进行中（未招募）1 期
Treatment of congenital nephrogenic diabetes insipidus with fluconazole, an antifungal medication
Claus Bistrup0 个研究点目标入组 10 人开始时间: 2020年5月7日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •-Age > 18 year
- •-Mentally capable of understanding the test
- •-Nephrogenic diabetes insipidus diagnosed by genetic defect in AVPR2
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 9
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 1
排除标准
- •-Other known relevant disease including malignity
- •-Contraindications to fluconazole
- •-Prolonged QT interval on baseline ECG
- •-Concurrent treatment with drugs metabolized by CYP3A4, CYP2C19 or CYP2C9
研究者
相似试验
进行中（未招募）
1 期
Treatment of congenital nephrogenic diabetes insipidus with riociguat or sildenafilephrogenic diabetes insipidus because of AVP2R-mutationMedDRA version: 20.0 Level: LLT Classification code 10012626 Term: Diabetes nephrogenic (excludes glycosuria) System Organ Class: 100000004857EUCTR2016-001591-30-DKOdense University Hospital2
尚未招募
2 期
Ayurvedic management of Diabetic Nephropathy (stage 1 and 2)CTRI/2022/09/045629All India Institue Of Ayurveda
已完成
3 期
Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A randomized, controlled, multicenter studyN04.9DRKS00006547niversitätsklinikum Heidelberg272
进行中（未招募）
1 期
Initial treatment of nephrotic syndrome in childreEUCTR2014-001991-76-DERuprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial340
招募中
2 期
Establishment of therapeutic strategy for renal cell carcinoma based on the evaluation by FDG PET/CTadvanced renal cell carcinomaJPRN-UMIN000008141Yokohama City University80